- Home
- WVVI vs TOVX Comparison
WVVI vs TOVX Comparison
Compare WVVI & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WVVI
- TOVX
- Stock Information
- Founded
- WVVI 1983
- TOVX 2001
- Country
- WVVI United States
- TOVX United States
- Employees
- WVVI N/A
- TOVX N/A
- Industry
- WVVI Beverages (Production/Distribution)
- TOVX Biotechnology: Pharmaceutical Preparations
- Sector
- WVVI Consumer Staples
- TOVX Health Care
- Exchange
- WVVI Nasdaq
- TOVX Nasdaq
- Market Cap
- WVVI 16.5M
- TOVX 3.2M
- IPO Year
- WVVI N/A
- TOVX 2006
- Fundamental
- Price
- WVVI $3.47
- TOVX $1.46
- Analyst Decision
- WVVI
- TOVX Strong Buy
- Analyst Count
- WVVI 0
- TOVX 1
- Target Price
- WVVI N/A
- TOVX $6.00
- AVG Volume (30 Days)
- WVVI 4.9K
- TOVX 1.0M
- Earning Date
- WVVI 11-12-2024
- TOVX 11-12-2024
- Dividend Yield
- WVVI N/A
- TOVX N/A
- EPS Growth
- WVVI N/A
- TOVX N/A
- EPS
- WVVI N/A
- TOVX N/A
- Revenue
- WVVI $39,259,016.00
- TOVX N/A
- Revenue This Year
- WVVI N/A
- TOVX N/A
- Revenue Next Year
- WVVI N/A
- TOVX N/A
- P/E Ratio
- WVVI N/A
- TOVX N/A
- Revenue Growth
- WVVI N/A
- TOVX N/A
- 52 Week Low
- WVVI $3.17
- TOVX $1.14
- 52 Week High
- WVVI $5.40
- TOVX $17.00
- Technical
- Relative Strength Index (RSI)
- WVVI 62.38
- TOVX 54.18
- Support Level
- WVVI $3.32
- TOVX $1.40
- Resistance Level
- WVVI $3.50
- TOVX $2.08
- Average True Range (ATR)
- WVVI 0.08
- TOVX 0.13
- MACD
- WVVI 0.03
- TOVX 0.06
- Stochastic Oscillator
- WVVI 90.91
- TOVX 36.17
About WVVI Willamette Valley Vineyards Inc.
Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.